Artelo BiosciencesARTL
13F holders, Q4 2025 (December 31)10holders +1
6new positions
5sold out
$1.22avg. 13F price*
At the end of Q4 2025, 10 institutions reported holding Artelo Biosciences Inc. (ARTL) in their 13F filings, up 1 from Q3 2025. 6 opened new positions and 5 sold out. The largest holders were UBS Group AG ($41K), Two Sigma Investments, LP ($25K) and Virtu Financial LLC ($21K).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G607
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $62K |
| Exits | 5 | $86K |
All 13F filers, Q3 2025 → Q4 2025: 84,255 shares bought and 18,793 shares sold, net +65,462 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| UBS Group AG | 0.00% | Add +15986.6% | 33,621 | $41K |
| Two Sigma Investments, LP | 0.00% | New | 20,669 | $25K |
| Virtu Financial LLC | 0.00% | New | 16,865 | $21K |
| Vanguard Group Inc. | 0.00% | No change | 14,028 | $17K |
| Geode Capital Management, LLC | 0.00% | New | 11,398 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,903 | $2K |
| Bank of America Corp. | 0.00% | Add +54.5% | 17 | $21 |
| Rothschild Investment LLC | 0.00% | No change | 2 | $2 |
| Osaic Holdings, Inc. | 0.00% | New | 1 | $1 |
| Cwm, LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is ARTL's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.